Sigma Healthcare Ltd ( (AU:SIG) ) has provided an announcement.
Sigma Healthcare Ltd announced a change in the interest of its director, Damien Gance. On February 14, 2025, Gance disposed of 40,000,000 ordinary shares held indirectly through various trusts, impacting his total shareholding in the company. This disposal may reflect strategic financial decisions or adjustments in the director’s investment portfolio, potentially influencing stakeholders’ perception of the company’s financial health and future prospects.
More about Sigma Healthcare Ltd
Sigma Healthcare Ltd operates in the healthcare industry, focusing on the distribution of pharmaceutical products and services across Australia. It plays a significant role in the supply chain, providing essential healthcare solutions and support to pharmacies and hospitals.
YTD Price Performance: 8.35%
Average Trading Volume: 8,655
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €21.69B
For detailed information about SIG stock, go to TipRanks’ Stock Analysis page.